The Individual Role of Sarcolemmal and Mitochondrial KATP Channels Opening During Cardiopulmonary Resuscitation in a Porcine Model Treated with Levosimendan

Objective: We investigated the individual role of the sarcolemmal KATP (sarcKATP) channel and the mitochondrial KATP (mitoKATP) channel opening during cardiac arrest and resuscitation by levosimendan administration to improve post-resuscitation myocardial function in a porcine model. Materials & Methods: Twenty pigs were randomized into 4 groups: 1) levosimendan (LEVO) + HMR-1098 (sarcKATP channel blocker): HMR-1098 3 mg/Kg was injected 30 min before inducing ventricular fibrillation (VF) and levosimendan 40 μg/kg was injected 3 min after inducing VF (VF 3); 2) LEVO + 5-HD (mitoKATP channel blocker): 5-HD 5 mg/Kg was injected 30 min before inducing VF and levosimendan 40 μg/kg was injected at VF 3; 3) LEVO: levosimendan 40 μg/kg was injected at VF 3; 4) control: an equal volume of saline placebo was injected at VF 3. VF was induced by intraluminal balloon occlusion of the left anterior descending coronary artery. After 7 min of untreated VF, CPR was initiated for 5 min followed by defibrillation. Resuscitated animals were observed for 4 hrs. Myocardial function was assessed by echocardiographic doppler measurements. To examine myocardial protection, we assessed measurements obtained from a PC-based data acquisition system, supported by CODAS/WINDAQ hardware/software, a stat profile analyzer and a lactic acid analyzer. Results: Pre-treatment of the sarcKATP channel blocker increased ventricular arrhythmia and the number of defibrillation shocks required. Blocking the mitoKATP channel completely abolished myocardial protective effects of LEVO. Beneficial effects of decreased ST segment elevation, reduced production of myocardial H+, and lactate and CO2 as observed following administration of LEVO no longer existed after blocking either channel. Conclusion: Activation of both channels by LEVO provides myocardial protective mechanisms. Activation of the sarcKATP channel reduces post-resuscitation ventricular arrhythmia, while activation of the mitoKATP channel improves myocardial mechanical function. Reduced myocardial H+, lactate and CO2 production was observed after activation of both channels. Copyright © 2017 The Authors. Published by Scientific Open Access Journals LLC.

[1]  F. Follath Newer treatments for decompensated heart failure: focus on levosimendan , 2009, Drug design, development and therapy.

[2]  M J Janse,et al.  Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. , 1990, Circulation research.

[3]  T. Flagg,et al.  Muscle KATP channels: recent insights to energy sensing and myoprotection. , 2010, Physiological reviews.

[4]  Wanchun Tang,et al.  Levosimendan improves cardiopulmonary resuscitation and survival by K(ATP) channel activation. , 2006, Journal of the American College of Cardiology.

[5]  Wanchun Tang,et al.  Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade. , 2005, The Journal of laboratory and clinical medicine.

[6]  T. Flagg,et al.  Sarcolemmal K(ATP) channels: what do we really know? , 2005, Journal of molecular and cellular cardiology.

[7]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[8]  T. Ng Levosimendan, a New Calcium‐Sensitizing Inotrope for Heart Failure , 2004, Pharmacotherapy.

[9]  Wanchun Tang,et al.  Levosimendan improves postresuscitation outcomes in a rat model of CPR. , 2005, The Journal of laboratory and clinical medicine.

[10]  P. Pollesello,et al.  Levosimendan is a mitochondrial KATP channel opener , 2001 .

[11]  A. Terzic,et al.  Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. , 1998, American journal of physiology. Heart and circulatory physiology.

[12]  Yongge Liu,et al.  Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? , 1998, Circulation.

[13]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[14]  E. Murphy,et al.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. , 2008, Physiological reviews.

[15]  G. Billman Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia. , 1994, Cardiovascular research.

[16]  M. Ashraf,et al.  Mechanisms by which K(ATP) channel openers produce acute and delayed cardioprotection. , 2005, Vascular pharmacology.

[17]  G. Lombardi,et al.  Outcome of Out-of-Hospital Cardiac Arrest in New York City: The Pre-Hospital Arrest Survival Evaluation (PHASE) Study , 1994 .

[18]  Russell L. Moore,et al.  Myocardial KATP channels are critical to Ca2+ homeostasis in the metabolically stressed heart in vivo. , 2007, American journal of physiology. Heart and circulatory physiology.

[19]  M. Weil,et al.  Myocardial dysfunction after successful resuscitation from cardiac arrest. , 1996, Critical care medicine.

[20]  B. O’Rourke,et al.  Cardiac mitochondria and arrhythmias. , 2010, Cardiovascular research.

[21]  M. Weil,et al.  K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  G. Gross,et al.  KATP channels and myocardial preconditioning: an update. , 2003, American journal of physiology. Heart and circulatory physiology.

[23]  A. Rowan Guide for the Care and Use of Laboratory Animals , 1979 .

[24]  Y. Rudy,et al.  Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration. , 1997, Cardiovascular research.

[25]  Mark E. Anderson,et al.  Reduction in number of sarcolemmal KATP channels slows cardiac action potential duration shortening under hypoxia. , 2011, Biochemical and biophysical research communications.

[26]  C. Mcpherson,et al.  Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. , 1993, The American journal of physiology.

[27]  J. Ornato,et al.  The Individual Role of Sarcolemmal and Mitochondrial KATP Channels Opening During Cardiopulmonary Resuscitation in a Porcine Model Treated with Levosimendan , 2017 .

[28]  Zhiyong Zhu,et al.  Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation. , 2011, Journal of molecular and cellular cardiology.

[29]  A. Kleber ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia. , 2000, Cardiovascular research.

[30]  Wanchun Tang,et al.  Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction* , 2005, Critical care medicine.

[31]  M. Weil,et al.  A comparison of biphasic and monophasic waveform defibrillation after prolonged ventricular fibrillation. , 2001, Chest.

[32]  M. Weil,et al.  Progressive myocardial dysfunction after cardiac resuscitation , 1993, Critical care medicine.